Skip to main content

Advertisement

Table 2 Patient Characteristics

From: Behavioral activation therapy for depression and anxiety in cancer patients: a case series study

No. Age Sex Cancer type Stage Treatment Psychiatric diagnosis Antidepressant/ Stabilizer Medication adjustment PHQ-9 GAD-7 CGI-I Complete or
          pre post pre post   Drop out
1 45 F Breast cancer II Chemotherapy Depression (moderate) Escitalopram Yes (discontinue) 15 2 8 4 2 Complete
2 62 F Lung cancer IV Chemotherapy Depression (moderate) Escitalopram
Lorazepam
Yes (increase) 15 1 15 2 1 Complete
3 48 F Breast cancer IV Chemotherapy Depression (moderate) Mirtazapine Yes (new prescription) 13 × 3 × × Drop out (brain metastasis)
4 66 F Endometrial cancer III Chemotherapy Depression (severe) Escitalopram
Alprazolam
Yes (increase) 19 19 19 18 3 Complete
5 66 F Ovarian cancer Recurrence Chemotherapy Depression (moderate) Nothing No 14 2 8 0 1 Complete
6 72 F Breast cancer IV Chemotherapy Adjustment disorder (with anxiety) Nothing No 6 1 6 0 1 Complete
7 56 F Breast cancer I Observation Adjustment disorder (with anxiety) Nothing No 6 3 10 4 2 Complete
8 57 F Breast cancer II Chemotherapy Adjustment disorder (with anxiety) Ethyl loflazepate
Alprazolam
No 20 4 18 6 1 Complete
9 62 M Laryngeal cancer Recurrence Observation Depression (moderate) Escitalopram
Ethyl loflazepate
No 24 9 15 6 1 Complete
10 44 F Breast cancer II Chemotherapy Depression (moderate) Nothing No 11 5 8 2 2 Complete